炎症性肠病患者结肠异型增生内镜下切除的系统评价与荟萃分析
该系统评价与荟萃分析检索多个数据库至2019年8月,纳入18项研究、1037例炎症性肠病(IBD)患者共1428处结肠病变,汇总内镜下切除异型增生后肿瘤发生风险。切除后结直肠癌(CRC)汇总风险为2/1000人年(95%CI 0-3),高级别异型增生汇总风险为2/1000人年(95%CI 1-3),任何病变汇总风险为43/1000人年(95%CI 30-57);基于病变位置、大小、类型、切除技术和组织学的荟萃回归分析未影响上述结局。作者认为IBD患者异型增生切除后CRC风险似乎较低,支持现行切除与监测策略。
要点
- 18项研究、1037例IBD患者共1428处结肠病变行内镜下切除。
- 切除后CRC汇总风险2/1000人年(95%CI 0-3),高级别异型增生2/1000人年(95%CI 1-3)。
- 任何病变汇总风险43/1000人年(95%CI 30-57)。
核心结论
- IBD患者异型增生内镜下切除后CRC风险似乎较低,支持现行切除与监测策略。
研究设计与样本
- 系统评价与荟萃分析,检索多个数据库自建库至2019年8月,纳入18项报告IBD患者异型增生切除后肿瘤发生率和/或复发的研究。
- 共1037例IBD患者接受内镜下切除,合计1428处结肠病变。
主要发现
- 病变切除后CRC汇总风险为2/1000人年(95%CI 0-3)。
- 高级别异型增生汇总风险为2/1000人年(95%CI 1-3)。
- 任何病变汇总风险为43/1000人年(95%CI 30-57)。
- 基于病变位置(右侧、左侧)、病变大小(平均和/或中位尺寸,mm)、病变类型(Paris I型、Paris II型)、内镜切除技术(EMR、内镜黏膜下剥离术或息肉切除术)和组织学(低级别异型增生、高级别异型增生)的荟萃回归分析未影响所报告的结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Inflammatory bowel disease (IBD) is a well-known risk factor for colorectal cancer (CRC). Current guidelines propose complete endoscopic resection of dysplasia in IBD patients with close endoscopic follow-up. Current data on the risk of neoplasia after endoscopic resection of dysplasia in IBD patients are limited. METHODS: Multiple databases were searched from inception through August 2019 to identify studies that reported on incidence and/or recurrence of neoplasia after resection of dysplasia in patients with IBD. Outcomes from the included studies were pooled to estimate the risk of neoplasia after dysplasia resection in IBD patients. RESULTS: From 18 studies, 1037 IBD patients underwent endoscopic resection for a total of 1428 colonic lesions. After lesion resection, the pooled risk (rate per 1000 person-years of follow-up) of CRC was 2 (95% confidence interval [CI], 0-3), the pooled risk of high-grade dysplasia was 2 (95% CI, 1-3), and the pooled risk of any lesion was 43 (95% CI, 30-57). Meta-regression analysis based on lesion location (right, left), lesion size (mean and/or median size in mm), lesion type (Paris type I, Paris type II), endoscopic resection technique (EMR, endoscopic submucosal dissection, or polypectomy), and lesion histology (low-grade dysplasia, high-grade dysplasia) did not influence the reported outcomes. CONCLUSIONS: Risk of CRC after dysplasia resection in IBD patients appears to be low, supporting the current strategy of resection and surveillance.
引用
- Mohan BP, Khan SR, Chandan S, et al. Endoscopic resection of colon dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis. Gastrointest Endosc. 2020. PMID: 32592777. doi:10.1016/j.gie.2020.06.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。